Nanobiotix
NBTX
9 hedge funds and large institutions have $46.5M invested in Nanobiotix in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
2.18% less ownership
Funds ownership: 13.93% → 11.75% (-2.2%)
10% less funds holding
Funds holding: 10 → 9 (-1)
31% less capital invested
Capital invested by funds: $66.9M → $46.5M (-$20.4M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$7.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tybourne Capital Management
Hong Kong
|
-$10.3M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$112K |
| 3 |
Millennium Management
New York
|
-$6.62K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $15.9M | – | – | – |
|
|
PA
2
Perceptive Advisors
New York
| $12M | – | – | – |
|
|
AG
3
Artal Group
Luxembourg
| $11.4M | – | – | – |
|
|
O
4
OrbiMed
New York
| $5.68M | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $686K | +$7.51K | +562 | +0.9% |
|
|
WP
6
Woodline Partners
San Francisco,
California
| $587K | -$112K | -8,359 | -14% |
|
|
7
Millennium Management
New York
| $246K | -$6.62K | -495 | -2% |
|
|
AWM
8
Activest Wealth Management
Aventure,
Florida
| $3K | – | – | – |
|
9
Morgan Stanley
New York
| $3K | – | – | – |
|
|
TCM
10
Tybourne Capital Management
Hong Kong
| – | -$10.3M | -750,000 | Closed |
|
NBTX Hedge Fund Activity: Q3 2021 in Review
9 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q3 2021, worth a combined $46.5M — down 31% from $66.9M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NBTX and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $7.51K. The largest seller was Tybourne Capital Management, exiting entirely with an estimated $10.3M sold.
- 9 institutional investors held Nanobiotix (NBTX) as of Q3 2021, down from 10 in Q2 2021.
- Funds reported $46.5M of Nanobiotix stock for Q3 2021, down 31% quarter-over-quarter.
- 0 funds opened new Nanobiotix positions in Q3 2021 and 1 closed out, a net change of -1 holder.
- The largest Nanobiotix buyer in Q3 2021 was UBS Group, an estimated $7.51K added.
- The largest Nanobiotix seller in Q3 2021 was Tybourne Capital Management, an estimated $10.3M sold.
Based on aggregated 13F filings for Q3 2021.